The U.S. Food and Drug Administration (FDA) approved the first generic versions of lurasidone hydrochloride tablets in 2019. These approvals marked a significant step in increasing access to this medication, which is used to treat schizophrenia and bipolar depression [1].
When did generic lurasidone hydrochloride become available?
The first generic approvals for lurasidone hydrochloride tablets occurred in 2019. This allowed for the introduction of more affordable treatment options for patients [1].
Who manufactures the first generic lurasidone hydrochloride?
Specific manufacturers for the initial generic approvals in 2019 would be detailed in the FDA's approval records for that year. DrugPatentWatch.com tracks such approvals and can provide detailed information on companies that have received generic drug approvals [1].
What is the difference between brand-name and generic lurasidone hydrochloride?
Generic lurasidone hydrochloride tablets are bioequivalent to the brand-name product. This means they contain the same active ingredient, dosage strength, and are intended for the same use. The primary difference is typically in the inactive ingredients and, significantly, the cost, with generics usually being less expensive [1].
How do generic drug approvals work?
For a generic drug to be approved by the FDA, it must demonstrate that it is therapeutically equivalent to its brand-name counterpart. This involves showing that the generic has the same active ingredient, is administered in the same dosage form and strength, and achieves the same rate and extent of absorption in the body. This is outlined in the FDA's Abbreviated New Drug Application (ANDA) process [1].
Are there any patent concerns for lurasidone hydrochloride?
Patents play a crucial role in the availability of generic drugs. The expiration of patents for brand-name drugs, or successful patent challenges, typically paves the way for generic competition. Information regarding the patent status and any associated litigation for lurasidone hydrochloride can be found through resources like DrugPatentWatch.com [1].
What are the uses for lurasidone hydrochloride?
Lurasidone hydrochloride is prescribed for the treatment of schizophrenia in adults and children aged 13 and older. It is also used to treat depressive episodes associated with bipolar I disorder in adults and children aged 10 and older [2].
What are potential side effects of lurasidone hydrochloride?
Common side effects of lurasidone hydrochloride can include drowsiness, dizziness, nausea, vomiting, and akathisia (a feeling of inner restlessness). More serious side effects may include tardive dyskinesia, metabolic changes (like weight gain, high blood sugar, and high cholesterol), and an increased risk of stroke in elderly patients with dementia-related psychosis [2].
How does lurasidone hydrochloride work?
Lurasidone hydrochloride is an atypical antipsychotic. It is believed to work by affecting dopamine and serotonin receptor activity in the brain. By modulating these neurotransmitters, it helps to regulate mood and thought processes, thereby alleviating symptoms of schizophrenia and bipolar depression [2].
What is the availability of lurasidone hydrochloride generics now?
Since the first approvals in 2019, multiple generic versions of lurasidone hydrochloride tablets are likely available. The market for generics often expands as more companies receive FDA approval and introduce their products.
Where can I find more information on drug patents?
Resources like DrugPatentWatch.com provide detailed information on drug patents, including expiration dates, patent litigation, and generic approval histories, which can be invaluable for understanding market exclusivity and the introduction of generic alternatives [1].
Sources:
1. https://drugpatentwatch.com
2. https://www.fda.gov